NemaMetrix is the market leader for early preclinical in-vivo testing using small animal models to gain a better understanding of the efficacy, mode of action, toxicity and potential targets for novel compounds. In this case study we outline how we used the animal model C. elegans to perform a set of specific experiments designed by our experts to provide rapid and reliable data based on our customer’s priorities. Using the data that we provided, our customer was able to apply for multiple patents in a timely manner.
Ben Jusilla presented his poster on using zebrafish for in-vivo disease modeling at ASHG and won the Reviewers’ Choice Award
How are extreme weather events, such as Hurricane Katrina, spreading heartworms and other parasitic nematodes and what are the implications of their spread?
Drug resistance in many pathogens — viruses, bacteria, protozoa, parasitic worms and more — presents a growing and potentially catastrophic challenge to human and animal health. Resistance is manifested by a decreased ability, or complete failure, of previously-effective drugs to successfully prevent or clear infections. Well-known human examples include methicillin-resistant Staphylococcus aureas (MRSA); multi-drug resistant […]
Our CSO revisits his Veritas Genomic Sequencing report for a closer look at how significant some of the discovered variants are